In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system

In this study, we prepared a helical, biocompatible, and biodegradable stent by 3D rapid prototyping. The fabricated polycaprolactone (PCL) stent was coated with sirolimus mixed with poly-(lactide-co-glycolide) (PLGA), and polyethylene glycol (PEG), via a spraying method for slow drug release. The engineered, drug-eluting, bio-absorbable vascular stent (BVS) was analyzed and tested in vivo, and proving effective in animal experiments. These findings suggest that our new approach is useful for treating coronary thrombosis, and it may provide a promising scaffold for developing biological stent technology.

[1]  J. Chae,et al.  Drug-eluting stent thrombosis during perioperative period. , 2008, International heart journal.

[2]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[3]  R. Whitbourn,et al.  First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). , 2013, JACC. Cardiovascular interventions.

[4]  M. Jeong,et al.  Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea. , 2012, International journal of cardiology.

[5]  Jong Chun Park,et al.  Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis , 2011, Korean circulation journal.

[6]  M. Jeong,et al.  Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs , 2012, Chonnam medical journal.

[7]  Kinam Park,et al.  Mechanisms of controlled drug release from drug-eluting stents. , 2006, Advanced drug delivery reviews.

[8]  Yoshinobu Onuma,et al.  Bioresorbable scaffolds: rationale, current status, challenges, and future. , 2014, European heart journal.

[9]  Su A. Park,et al.  Fabrication of nano/microfiber scaffolds using a combination of rapid prototyping and electrospinning systems , 2011 .

[10]  M. P. Judkins,et al.  Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application , 1964, Circulation.